Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Navigating Technology Transfer
Bringing the Freezing of Biopharmaceuticals in From the Cold
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
View All Featured ArticlesHeadline News
FDA grants accelerated approval to Nelkarmi for previously treated ALK-positive lung cancer
Johnson & Johnson to acquire Ollin Biosciences for $2.2bn to expand ophthalmology pipeline
FDA clears expanded ENT indication for Johnson & Johnson’s HARMONIC 1100 Shears
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Advanced digitalization plan for AstraZeneca’s CDC line
Presented by Melanie Dumarey, Product and process design engineer (associate principal scientist) at AstraZeneca
15th March 2023
Vaccine Development & its Manufacturing using Integrated High Throughput Technology
Presented by Dr. S.K. Jana, Director - R&D and Manufacturing, Human Vaccine Development, Serum Institute of India Pvt. Ltd. and Vikas Revankar, Head of Product Management and Marketing - Digital Portfolio, BioContinuum™ Platform - Merck and Piergiuseppe Nestola, PhD Global Vaccine Technology Consultant at Sartorius
20th September 2021
Risk Assessment of Extractables and Leachables in Different Phases of Development.
Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals and Ward d’Autry, Study Director E/L & Structural Elucidation, Nelson Labs Europe
22nd April 2021
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere TM A3
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Strategy Emerging Markets for Risk Mitigation
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















